Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 22;15(17):4203.
doi: 10.3390/cancers15174203.

Overexpression of E6/E7 mRNA HPV Is a Prognostic Biomarker for Residual Disease Progression in Women Undergoing LEEP for Cervical Intraepithelial Neoplasia 3

Maria Teresa Bruno  1   2 , Giulia Bonanno  3 , Francesco Sgalambro  4 , Antonino Cavallaro  4 , Sara Boemi  2
Affiliations

Overexpression of E6/E7 mRNA HPV Is a Prognostic Biomarker for Residual Disease Progression in Women Undergoing LEEP for Cervical Intraepithelial Neoplasia 3

Maria Teresa Bruno et al. Cancers (Basel). .

Abstract

The risk of overtreatment or not treating an occult carcinoma exists in women at risk of residual disease after a LEEP excision for CIN3. Our goal was to discover an efficient method to select patients requiring a second LEEP from those requiring a FU only through an mRNA-detection test. In a population of 686 women undergoing a LEEP excision for CIN 3, we selected 285 women at risk of residual disease and subjected them to a search for E6/E7 mRNA HPV. The women with negative mRNA were subjected to a follow up, while the women with positive mRNA were subjected to a second LEEP. The histological examination of the second cone revealed 120 (85.7%) cases of residual disease in the mRNA-positive women: 40 cases of CIN2, 51 cases of CIN3, 11 cases of squamous microinvasive carcinoma, 7 cases of squamous carcinoma, 9 cases of AIS (adenocarcinoma in situ) and 2 cases of adenocarcinoma. Among the mRNA-negative women undergoing a follow up, there were only five cases of residual disease. During the follow-up period of about 6 years, we witnessed the regression of the residual disease and the elimination of the virus, just as predicted by the negative result of the mRNA test. Testing patients for E6/E7 mRNA allowed us to identify women with residual disease (CIN2+) and treat them appropriately.

Keywords: CIN3; E6/E7 mRNA HPV; HPV persistence; LEEP; positive margin; residual disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow-chart of study population.
See this image and copyright information in PMC

References

    1. Centers for Disease Control and Prevention How Many Cancers Are Linked with HPV Each Year? [(accessed on 15 May 2022)];2014 Available online: http://www.cdc.gov/cancer/hpv/statistics/cases.htm.
    1. Bruno M.T., Ferrara M., Fava V., Rapisarda A., Coco A. HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women. Virol. J. 2018;15:52. doi: 10.1186/s12985-018-0957-z. - DOI - PMC - PubMed
    1. Trottier H., Franco E.L. The epidemiology of genital human papillomavirus infection. Vaccine. 2006;24((Suppl. S1)):S1–S15. doi: 10.1016/j.vaccine.2005.09.054. - DOI - PubMed
    1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. World Health Organization. International Agency for Research on Cancer Human Papillomaviruses . Human Papillomaviruses. International Agency for Research on Cancer; Lyon, France: 2007.
    1. Bruno M.T., Ferrara M., Fava V., Barrasso G., Cutello S., Sapia F., Panella M.M. Prevalence genotypes and distribution of human papillomavirus infection in women with abnormal cervical cytology in Catania, Italy. G. Ital. Di Ostet. E Ginecol. 2016;38:376–380. doi: 10.11138/giog/2016.38.5.376. - DOI

LinkOut - more resources